SPINT1 and pituitary gland adenoma: In previous studies, SPINT1-AS1 has been confirmed as a potential biomarker for renal clear cell carcinoma [23], Furthermore, it has also been identified as an independent prognostic indicator in pituitary adenoma, colorectal cancer, esophageal squamous cell carcinoma, and melanoma [24–27].